Marknadsmeddelande 242/16 – Sista dag för handel med Hamlet TO 2

18 October 2016 - 16:39

Sista dag för handel i bolagets teckningsoption, Hamlet TO 2, är den 21 oktober 2016.

Information om teckningsoptionen:

Kortnamn: HAMLET TO 2
ISIN-kod: SE0007192042
Orderboks ID: 114253
Sista handelsdag: Den 21 oktober 2016

Stockholm den 18 oktober, 2016

För mer information, vänligen kontakta AktieTorget på telefon 08-511 68 000 eller via
[email protected]

Provided by: Cision
Spotlight Stock Market (Sweden)
Hamlet Pharma AB
Hamlet Pharma is a pharmaceutical company. Most research and development is carried out in the field of protein-lipid complexes, which are used in the treatment of various forms of cancer. The company has developed a tumoricidal protein-lipid complex that mainly is used in the treatment of breast cancer, bladder cancer, as well as in cases of cancer that are hard to treat. The company is based in...
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More